Transaction · 0001213900-26-098970

Shenouda Maged

Shenouda Maged, CFO, reported an open-market or private purchase at RELMADA THERAPEUTICS, INC. involving 79800.000000 shares for an estimated $339150.00. Reported holdings after the transaction were 1000000.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code PCFO
RLMDRELMADA THERAPEUTICS, INC.
Trade date
Sep 10, 2026
Filing date
Sep 11, 2026
View on SEC Insider profile
Disclosed value$339kShares × reported price
Shares traded79.8k$4.25 per share
Holdings after1.00MDirect
% of reported position traded8.67%This security and ownership context
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 920,200 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

RLMD price since this filing

Daily closing prices, with the filing date and available return windows
RLMD · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d -8.6%30d -24.8%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Buy
Code P
Identifier
0001213900-26-098970
Common Stock
Transaction date
Sep 10, 2026
Filed Sep 11, 2026, 11:30 AM · 1d delay
Shares
79,800 sh
$4.25 per share
Estimated value
$339k
Computed from shares × price
Holdings after
1,000,000 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
CFO Buy Cluster Buy Direct Ownership Repeat Buyer
Filing-only score

+54 points

Compact filing score computed from stored Form 4 facts. Version v1.

Strong filing signal

This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.

How this score is calculated
  • open_market_purchase+12 points

    transaction_code = P

    Code P is a discretionary open-market purchase.
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • cfo_buy+10 points

    is_officer + officer_title/role mentions CFO

    CFO open-market purchase.
  • cluster_buy+14 points

    cluster-buy signal matched

    Multiple insiders bought within the configured window.
  • repeat_buyer+8 points

    repeat-buyer signal matched

    Same insider bought again within the configured window.
  • timely_filing+4 points

    reporting_delay_days = 1

    Filing reported within two business days of the transaction.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Financial Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted av…

  2. F2

    Purchase prices range from $4.16 to $4.20 per share, inclusive.

Original filing · 0001213900-26-098970
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

RLMD